Ensign Peak Advisors Inc Buys 1,322 Shares of Veralto Co. (NYSE:VLTO)

Ensign Peak Advisors Inc lifted its stake in shares of Veralto Co. (NYSE:VLTO) by 0.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 208,363 shares of the company’s stock after buying an additional 1,322 shares during the period. Ensign Peak Advisors Inc owned about 0.08% of Veralto worth $21,222,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Vanguard Group Inc. grew its stake in shares of Veralto by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 29,347,185 shares of the company’s stock worth $2,989,011,000 after acquiring an additional 146,234 shares in the last quarter. Amundi boosted its holdings in Veralto by 2.3% during the fourth quarter. Amundi now owns 7,169,702 shares of the company’s stock worth $731,084,000 after purchasing an additional 158,342 shares during the last quarter. Geode Capital Management LLC grew its position in Veralto by 12.5% in the 4th quarter. Geode Capital Management LLC now owns 6,601,676 shares of the company’s stock worth $670,781,000 after purchasing an additional 733,056 shares in the last quarter. Pictet Asset Management Holding SA increased its stake in Veralto by 1.2% in the 4th quarter. Pictet Asset Management Holding SA now owns 4,764,889 shares of the company’s stock valued at $485,304,000 after buying an additional 54,795 shares during the last quarter. Finally, Invesco Ltd. lifted its position in shares of Veralto by 9.7% during the 4th quarter. Invesco Ltd. now owns 4,541,367 shares of the company’s stock worth $462,538,000 after buying an additional 401,228 shares in the last quarter. Institutional investors own 91.28% of the company’s stock.

Insider Buying and Selling at Veralto

In related news, SVP Melissa Aquino sold 463 shares of Veralto stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $99.60, for a total transaction of $46,114.80. Following the completion of the sale, the senior vice president now owns 20,761 shares of the company’s stock, valued at approximately $2,067,795.60. This trade represents a 2.18 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Surekha Trivedi sold 590 shares of the company’s stock in a transaction dated Tuesday, February 25th. The stock was sold at an average price of $100.35, for a total value of $59,206.50. Following the completion of the transaction, the senior vice president now owns 8,470 shares in the company, valued at $849,964.50. This represents a 6.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 64,578 shares of company stock valued at $6,192,048 in the last quarter. 0.36% of the stock is currently owned by corporate insiders.

Veralto Stock Performance

NYSE VLTO opened at $97.07 on Friday. The firm has a market cap of $24.06 billion, a P/E ratio of 29.06, a price-to-earnings-growth ratio of 4.24 and a beta of 0.99. The company has a quick ratio of 1.69, a current ratio of 1.92 and a debt-to-equity ratio of 1.27. The company’s 50 day moving average is $94.22 and its 200-day moving average is $99.78. Veralto Co. has a 12-month low of $83.87 and a 12-month high of $115.00.

Veralto (NYSE:VLTO) last issued its earnings results on Tuesday, April 29th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.08. Veralto had a net margin of 16.04% and a return on equity of 49.29%. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.28 billion. During the same quarter in the previous year, the firm posted $0.84 EPS. The business’s revenue for the quarter was up 6.9% compared to the same quarter last year. Sell-side analysts predict that Veralto Co. will post 3.66 earnings per share for the current year.

Veralto Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st were paid a $0.11 dividend. The ex-dividend date was Monday, March 31st. This represents a $0.44 annualized dividend and a yield of 0.45%. Veralto’s dividend payout ratio is currently 12.57%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on VLTO shares. Robert W. Baird increased their price target on Veralto from $105.00 to $106.00 and gave the company a “neutral” rating in a research report on Thursday, May 1st. Stifel Nicolaus raised their target price on Veralto from $102.00 to $104.00 and gave the company a “buy” rating in a research report on Thursday, May 1st. Northcoast Research began coverage on shares of Veralto in a report on Tuesday, May 6th. They issued a “buy” rating and a $110.00 price target on the stock. Citigroup decreased their price objective on shares of Veralto from $116.00 to $100.00 and set a “neutral” rating for the company in a report on Monday, April 14th. Finally, Royal Bank of Canada boosted their target price on shares of Veralto from $103.00 to $104.00 and gave the company a “sector perform” rating in a research note on Thursday, May 1st. Six research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $110.09.

Veralto Company Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.